The dual role of pharmacogenetics in HIV treatment: mutations and polymorphisms regulating antiretroviral drug resistance and disposition
Significant intra-and interindividual variability has been observed in response to use of
pharmacological agents in treatment of HIV infection. Treatment of HIV infection is limited by …
pharmacological agents in treatment of HIV infection. Treatment of HIV infection is limited by …
[HTML][HTML] Human immunodeficiency virus infection and the liver
Liver disease in human immunodeficiency virus (HIV)-infected individuals encompasses the
spectrum from abnormal liver function tests, liver decompensation, with and without …
spectrum from abnormal liver function tests, liver decompensation, with and without …
Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons
L Ryom, JD Lundgren, S De Wit, H Kovari, P Reiss… - Aids, 2016 - journals.lww.com
Objectives: Although several antiretroviral drugs, including the d-drugs stavudine (d4T) and
didanosine (ddI), may cause biomarker-defined hepatotoxicity, their association with …
didanosine (ddI), may cause biomarker-defined hepatotoxicity, their association with …
[HTML][HTML] Detection of hepatotoxicity potential with metabolite profiling (metabolomics) of rat plasma
W Mattes, K Davis, E Fabian, J Greenhaw, M Herold… - Toxicology letters, 2014 - Elsevier
While conventional parameters used to detect hepatotoxicity in drug safety assessment
studies are generally informative, the need remains for parameters that can detect the …
studies are generally informative, the need remains for parameters that can detect the …
Drug-induced liver injury: a summary of recent advances
JG Stine, JH Lewis - Expert opinion on drug metabolism & …, 2011 - Taylor & Francis
Introduction: The knowledge base of drug-induced liver injury (DILI) continues to grow each
year as additional drugs are identified as hepatotoxins. There is still a need to improve our …
year as additional drugs are identified as hepatotoxins. There is still a need to improve our …
Animal models of idiosyncratic drug reactions
W Ng, ARM Lobach, X Zhu, X Chen, F Liu… - Advances in …, 2012 - Elsevier
If we could predict and prevent idiosyncratic drug reactions (IDRs) it would have a profound
effect on drug development and therapy. Given our present lack of mechanistic …
effect on drug development and therapy. Given our present lack of mechanistic …
Cohort profile: the Khayelitsha antiretroviral programme, Cape town, South Africa
K Stinson, E Goemaere, D Coetzee… - International Journal …, 2017 - academic.oup.com
Khayelitsha is Cape Town's largest township, approximately 35km from the city centre. It was
originally developed as a dormitory town to house the increasing influx of African migrant …
originally developed as a dormitory town to house the increasing influx of African migrant …
Hepatotoxicity and associated risk factors in HIV-infected patients receiving antiretroviral therapy at Felege Hiwot Referral Hospital, Bahirdar, Ethiopia
Background: In Human Immunodeficiency Virus (HIV) infected patients on antiretroviral
treatment (ART), hepatotoxicity is life threatening. Its outcome may lead to liver failure and …
treatment (ART), hepatotoxicity is life threatening. Its outcome may lead to liver failure and …
The impact of illustrated side effect information on understanding and sustained retention of antiretroviral side effect knowledge
SH Browne, K Barford, T Ramela, R Dowse - Research in Social and …, 2019 - Elsevier
Background Prompt management of side effects is critical to supporting adherence to
antiretroviral (ARV) medication. Objective This study examines the impact of presenting side …
antiretroviral (ARV) medication. Objective This study examines the impact of presenting side …
Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti …
H Kovari, CA Sabin, B Ledergerber… - Clinical infectious …, 2013 - academic.oup.com
Background. Liver diseases are the leading causes of death in human immunodeficiency
virus (HIV)–positive persons since the widespread use of combination antiretroviral …
virus (HIV)–positive persons since the widespread use of combination antiretroviral …